Literature DB >> 9464512

Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method.

M Furutani1, S Arii, M Mizumoto, M Kato, M Imamura.   

Abstract

To identify the intercellular signal-transducing proteins and receptors produced by cancer cells, we attempted to clone cDNAs encoding secreted and type I membrane proteins using a signal sequence trap (SST) method with some modifications. By screening an SST library derived from pancreatic cancer cells, we identified two secretory proteins (neutrophil gelatinase-associated lipocalin (NGAL) and lung surfactant protein D) and three membrane proteins (carcinoembryonic antigen, BiP/GRP78 and Hsa4 mitochondrion cytochrome oxidase subunit II). NGAL mRNA was expressed in eight of the pancreatic cancer cell lines and eight pancreatic cancer tissues. The expression of NGAL mRNA was also observed in colorectal and hepatic tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9464512     DOI: 10.1016/s0304-3835(97)00391-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  32 in total

1.  Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.

Authors:  Adnan N Kiani; Tianfu Wu; Hong Fang; Xin J Zhou; Chul W Ahn; Laurence S Magder; Chandra Mohan; Michelle Petri
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

2.  Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival.

Authors:  Herbert Thomas Maier; Felix Aigner; Birgit Trenkwalder; Matthias Zitt; Natalie Vallant; Alexander Perathoner; Christian Margreiter; Patrizia Moser; Johann Pratschke; Albert Amberger
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

3.  Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis.

Authors:  Clara Luz Sampieri; Sol de la Peña; Mariana Ochoa-Lara; Roberto Zenteno-Cuevas; Kenneth León-Córdoba
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

4.  A novel alternative spliced variant of neutrophil gelatinase-associated lipocalin receptor in oesophageal carcinoma cells.

Authors:  Wang-Kai Fang; Li-Yan Xu; Xiao-Feng Lu; Lian-Di Liao; Wei-Jia Cai; Zhong-Ying Shen; En-Min Li
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

5.  Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.

Authors:  Zhimin Tong; Ajaikumar B Kunnumakkara; Huamin Wang; Yoichi Matsuo; Parmeswaran Diagaradjane; Kuzhuvelil B Harikumar; Vijaya Ramachandran; Bokyung Sung; Arup Chakraborty; Robert S Bresalier; Craig Logsdon; Bharat B Aggarwal; Sunil Krishnan; Sushovan Guha
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 6.  Molecular chaperones in the etiology and therapy of cancer.

Authors:  C Soti; P Csermely
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

7.  Circulating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia.

Authors:  Sun Min Kim; Joong Shin Park; Errol R Norwitz; Hee Jung Jung; Byoung Jae Kim; Chan-Wook Park; Jong Kwan Jun
Journal:  Reprod Sci       Date:  2013-02-25       Impact factor: 3.060

8.  Neutrophil gelatinase-associated lipocalin as a survival factor.

Authors:  Zhimin Tong; Xuli Wu; Dmitriy Ovcharenko; Jiuxiang Zhu; Ching-Shih Chen; James P Kehrer
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

9.  Lipocalin 2 is required for BCR-ABL-induced tumorigenesis.

Authors:  X Leng; H Lin; T Ding; Y Wang; Y Wu; S Klumpp; T Sun; Y Zhou; P Monaco; J Belmont; A Aderem; S Akira; R Strong; R Arlinghaus
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

10.  Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer.

Authors:  HanByoul Cho; Jae-Hoon Kim
Journal:  J Histochem Cytochem       Date:  2009-02-02       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.